Capital Analysts LLC’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
Capital Analysts LLC's SLS Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 4,000 shares worth $49.2K. The stake represents ﹤0.01% of the portfolio and ranks #1013 among its holdings.
218 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Capital Analysts LLC held 4,000 shares of SELLAS Life Sciences worth $49.2K as of Q3 2026.
- SELLAS Life Sciences was a new Capital Analysts LLC position in Q3 2026.
- SELLAS Life Sciences made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1013 holding.
- 218 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.